ask="4.42"
ask_size="300"
average_daily_volume="552820"
bid="4.15"
bid_size="100"
book_value="3.74"
change="-0.08"
change_from_200_day_moving_average="2.48"
change_from_50_day_moving_average="0.41"
change_from_52_week_high="-2.41"
change_From_52_week_low="3.49"
change_in_percent="-1.82%"
close="4.31"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13385000"
high="4.42"
high_52_weeks="6.72"
last_trade_date="12/30/2016"
last_trade_price="4.31"
last_trade_size="6009"
last_trade_time="4:00pm"
low="4.24"
low_52_weeks="0.82"
market_capitalization="97.19M"
moving_average_200_day="1.83"
moving_average_50_day="3.90"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.34"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+135.44%"
percent_change_from_50_day_moving_average="+10.41%"
percent_change_from_52_week_high="-35.86%"
percent_change_from_52_week_low="+425.61%"
previous_close="4.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.17"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="5.06"
stock_exchange="NMS"
symbol="CASC"
volume="266987"
weeks_range_52="0.82 - 6.72"
